Process for the preparation of pyrazolylaminoquinazoline derivatives comprising a phosphate group

Details for Australian Patent Application No. 2007251395 (hide)

Owner AstraZeneca AB

Inventors Sependa, George Joseph; Pittam, John David

Agent Davies Collison Cave

Pub. Number AU-B-2007251395

PCT Pub. Number WO2007/132210

Priority 0609617.6 16.05.06 GB

Filing date 14 May 2007

Wipo publication date 22 November 2007

Acceptance publication date 6 January 2011

International Classifications

C07F 9/02 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

20 November 2008 PCT application entered the National Phase

  PCT publication WO2007/132210 Priority application(s): WO2007/132210

6 January 2011 Application Accepted

  Published as AU-B-2007251395

12 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007251399-Security inks containing infrared absorbing metal compounds

2007251394-New fetal methylation markers